Amgen (United Kingdom)

Amgen (United Kingdom)

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Amgen (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

62%


Total
Publications

708


Total Open
Publications

438


Total
Citations

24K


Open Access
Percentage

62%


Total
Publications

708


Total Open
Publications

438


Total
Citations

24K

Wikipedia

Website

download

Breakdown

27% 33% 2% 38%

Publisher Open

27%

Both

33%

Other Platform Open

2%

Closed

38%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

24%OA Journal

OA Journal 24%

102

Hybrid 54%

226

No Guarantees 22%

91

Other Platform Open

Domain 68%

169

Institution 48%

118

Other Internet 15%

38

Public 4%

9

Preprint 0%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
170
DANS - Data Archiving and Networked Services
Institution
29
DOI
Other Internet
27
Unknown Repository
Other Internet
17
Academy of Humanities and Economics in Lodz - Homo Politicus
Institution
12
Imperial College London - Spiral
Institution
9
Figshare
Public
9
Elsevier - Scopus
Institution
9
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
8
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
8
1 / 8

Data updated 18 August 2025

Share

Share

Share